- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| AVBP | Arrivent BioPharma Inc | 5.34% | 1,682,097 | $58,436,050 | 796,181 | 89.87% | $34.74 | 13F |
| ABVX | Abivax SA - ADR | 5.05% | 414,899 | $55,289,441 | 175,360 | 73.21% | $133.26 | 13F |
| TENX | Tenax Therapeutics Inc | 3.32% | 2,500,000 | $36,375,000 | 2,291,667 | 1100% | $14.55 | 13F |
| ACRS | Aclaris Therapeutics, Inc. | 3.23% | 6,694,637 | $35,414,630 | 27,971 | 0.42% | $5.29 | 13F |
| ANRO | Alto Neuroscience Inc | 2.91% | 1,208,858 | $31,901,763 | 173,307 | 16.74% | $26.39 | 13F |
| MLTX | Moonlake Immunotherapeutics | 2.49% | 1,400,000 | $27,258,000 | 400,000 | 40% | $19.47 | 13F |